… MAbs enhance the anticancer activity of chemotherapeutic agents such as cisplatin,
doxorubicin, irinotecan, paclitaxel, and topotecan [136-139]. Also, it was noticed that cetuximab …

… Epidermal Growth Factor Receptor (EGFR) Inhibitors The epidermal growth factor receptor
(EGFR) is a receptor … role in the physiology of epithelial cells by regulating several cellular …

… Epidermal growth factor receptor (EGFR) inhibitors are valuable therapeutics in metastatic
colorectal cancer (mCRC). Anti-EGFR monoclonal antibodies (MoAbs), such as cetuximab or …

… epidermal growth factor receptor (EGFR) family (also known as the human epidermal growth
factor receptor … (ERBB) family) belongs to the receptor tyrosine kinase (RTK) superfamily, …

… from that seen with traditional chemotherapeutic agents. PPES with cytotoxic agents such as
… With VEGFR/platelet‐derived growth factor receptor multikinase inhibitors, painful blisters …

… The purpose of this guideline update is to provide oncologists, … patients with human epidermal
growth factor receptor 2 (HER2)… updated the guidelines in 2018.The goal of this guideline …

… the combination of other RTK inhibitors and VEGFR inhibitors exerted a favorable clinical …
of the dual epidermal growth factor receptor (EGFR) inhibitor cetuximab and VEGFR inhibitor …

… The discovery of human epidermal growth factor receptor 2 (HER2) overexpression in 15–20…
new therapeutic targets and to develop new antitumor agents to improve patient outcomes. …

… to the vascular endothelial growth factor receptor (VEGFR) (11). … Epidermal growth factor
receptor and VEGF share a common … phase III RCTs, we will update the pooled results. Overall …

… as adjuvants to chemotherapeutic drugs in TNBC cells [6, 7]. … cancer cell growth by enhancing
the chemotherapeutic-… the nuclear factor-κB (NF- κβ), the epidermal growth factor receptor (…